Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Sarah Bhagat
Individual Investor

Sarah Bhagat

Overview

Edit Overview Section
Number of Current Board & Advisor Roles 3
CB Rank (Investor) 195,916
  • Investor Type 
    obfuscation
Sarah Bhagat is the Board Member at Inozyme Pharma. He attended Yale University and Stanford University Graduate School of Business.

Partner Investments

Edit Partner Investments Section
Number of Partner Investments 2
Announced Date  
Organization Name  
Investor Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Atsena Therapeutics Logo
Atsena Therapeutics
Sofinnova Investments Logo
Sofinnova Investments
Yes
Series A - Atsena Therapeutics Logo
Series A - Atsena Therapeutics
obfuscation
obfuscation
Inozyme Logo
Inozyme
Sofinnova Investments Logo
Sofinnova Investments
Yes
Series A - Inozyme Logo
Series A - Inozyme
obfuscation

Jobs

Edit Jobs Section
Number of Current Jobs 1
Number of Past Jobs 1
Sarah Bhagat is the Neuroscience: Translate Oversight Committee at Stanford University School of Medicine. Additionally, Sarah Bhagat has had 1 past job as the General Partner at Sofinnova Investments.
Organization Name  
Title At Company  
Start Date  
End Date  
Sofinnova Investments Logo
Sofinnova Investments
General PartnerMay 2017Aug 2022

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 3
Sarah Bhagat holds 3 board and advisor roles including Advisor at Atsena Therapeutics, Board Member at Atsena Therapeutics, and Board Member at Inozyme.

Education

Edit Education Section
Sarah Bhagat studied at Yale University and  Stanford Graduate School of Business.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 2
News•Dec 21, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 8, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(53d292a 1)
|